

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50707961 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.08493157 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.08493157 |
| 4 | regulation of gamma-delta T cell activation (GO:0046643) | 3.53631922 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 3.50459261 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.50459261 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.50459261 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.50459261 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 3.50459261 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 3.50459261 |
| 11 | B cell receptor signaling pathway (GO:0050853) | 3.47298626 |
| 12 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.46966282 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.41452012 |
| 14 | negative thymic T cell selection (GO:0045060) | 3.39616356 |
| 15 | germinal center formation (GO:0002467) | 3.37861992 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.36420425 |
| 17 | L-phenylalanine catabolic process (GO:0006559) | 3.36420425 |
| 18 | negative T cell selection (GO:0043383) | 3.35417884 |
| 19 | detection of molecule of bacterial origin (GO:0032490) | 3.29435344 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.25673133 |
| 21 | response to interleukin-15 (GO:0070672) | 3.22486639 |
| 22 | response to peptidoglycan (GO:0032494) | 3.21664739 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 3.21582551 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 3.16396062 |
| 25 | T cell migration (GO:0072678) | 3.14358362 |
| 26 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.12461602 |
| 27 | negative regulation of T cell mediated immunity (GO:0002710) | 3.11293378 |
| 28 | cellular response to type I interferon (GO:0071357) | 3.09113438 |
| 29 | type I interferon signaling pathway (GO:0060337) | 3.09113438 |
| 30 | response to type I interferon (GO:0034340) | 3.08458979 |
| 31 | positive thymic T cell selection (GO:0045059) | 3.06677669 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.04609431 |
| 33 | cellular extravasation (GO:0045123) | 3.03614717 |
| 34 | mature B cell differentiation (GO:0002335) | 3.02701010 |
| 35 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.00831553 |
| 36 | L-phenylalanine metabolic process (GO:0006558) | 3.00831553 |
| 37 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00548935 |
| 38 | response to muramyl dipeptide (GO:0032495) | 2.97888179 |
| 39 | alpha-linolenic acid metabolic process (GO:0036109) | 2.95710536 |
| 40 | detection of other organism (GO:0098543) | 2.91395530 |
| 41 | positive regulation of B cell differentiation (GO:0045579) | 2.89955610 |
| 42 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.86972872 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 2.85721760 |
| 44 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.85579154 |
| 45 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.83640230 |
| 46 | detection of external biotic stimulus (GO:0098581) | 2.83100054 |
| 47 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.82878783 |
| 48 | positive regulation of interferon-alpha production (GO:0032727) | 2.82857165 |
| 49 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.82491094 |
| 50 | response to host (GO:0075136) | 2.82491094 |
| 51 | response to host defenses (GO:0052200) | 2.82491094 |
| 52 | growth hormone receptor signaling pathway (GO:0060396) | 2.82237671 |
| 53 | regulation of necroptotic process (GO:0060544) | 2.81549575 |
| 54 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.80661077 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.79892948 |
| 56 | mature B cell differentiation involved in immune response (GO:0002313) | 2.78472387 |
| 57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78196283 |
| 58 | response to host immune response (GO:0052572) | 2.78196283 |
| 59 | immunoglobulin mediated immune response (GO:0016064) | 2.76397058 |
| 60 | positive T cell selection (GO:0043368) | 2.75836800 |
| 61 | valine metabolic process (GO:0006573) | 2.74839371 |
| 62 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.74274343 |
| 63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.73794890 |
| 64 | B cell homeostasis (GO:0001782) | 2.73406961 |
| 65 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.73307205 |
| 66 | regulation of interferon-alpha production (GO:0032647) | 2.72500609 |
| 67 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.72473481 |
| 68 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.72144554 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 2.70043783 |
| 70 | aromatic amino acid family catabolic process (GO:0009074) | 2.69664580 |
| 71 | low-density lipoprotein particle clearance (GO:0034383) | 2.69597374 |
| 72 | detection of bacterium (GO:0016045) | 2.68839613 |
| 73 | regulation of B cell differentiation (GO:0045577) | 2.67903590 |
| 74 | NIK/NF-kappaB signaling (GO:0038061) | 2.67504048 |
| 75 | membrane raft organization (GO:0031579) | 2.67092986 |
| 76 | B cell proliferation (GO:0042100) | 2.66380992 |
| 77 | regulation of triglyceride catabolic process (GO:0010896) | 2.65956976 |
| 78 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.63180439 |
| 79 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.61786043 |
| 80 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.60328554 |
| 81 | regulation of germinal center formation (GO:0002634) | 2.60316679 |
| 82 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.59879367 |
| 83 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.59879367 |
| 84 | positive regulation of macrophage cytokine production (GO:0060907) | 2.59863524 |
| 85 | regulation of macrophage cytokine production (GO:0010935) | 2.59845697 |
| 86 | thymic T cell selection (GO:0045061) | 2.59332509 |
| 87 | complement activation, alternative pathway (GO:0006957) | 2.58725181 |
| 88 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.57232502 |
| 89 | protein carboxylation (GO:0018214) | 2.56934816 |
| 90 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.56934816 |
| 91 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.56702391 |
| 92 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.56582681 |
| 93 | T-helper 1 type immune response (GO:0042088) | 2.55228647 |
| 94 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.53975954 |
| 95 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.53975954 |
| 96 | T cell selection (GO:0045058) | 2.53362463 |
| 97 | hepatocyte apoptotic process (GO:0097284) | 2.52298280 |
| 98 | tolerance induction (GO:0002507) | 2.51934694 |
| 99 | positive regulation of interleukin-2 production (GO:0032743) | 2.51752022 |
| 100 | regulation of B cell proliferation (GO:0030888) | 2.51370919 |
| 101 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.49404636 |
| 102 | leukocyte aggregation (GO:0070486) | 2.48814856 |
| 103 | microglial cell activation (GO:0001774) | 2.47186927 |
| 104 | detection of biotic stimulus (GO:0009595) | 2.46051693 |
| 105 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.44625502 |
| 106 | phospholipid efflux (GO:0033700) | 2.44368772 |
| 107 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.43685116 |
| 108 | positive regulation of granulocyte differentiation (GO:0030854) | 2.43638984 |
| 109 | defense response to protozoan (GO:0042832) | 2.43629810 |
| 110 | phospholipid homeostasis (GO:0055091) | 2.42649325 |
| 111 | bile acid biosynthetic process (GO:0006699) | 2.42134712 |
| 112 | positive regulation of B cell proliferation (GO:0030890) | 2.41007227 |
| 113 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.40692626 |
| 114 | macrophage activation (GO:0042116) | 2.40658264 |
| 115 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.40510473 |
| 116 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.40100358 |
| 117 | cellular response to growth hormone stimulus (GO:0071378) | 2.37703046 |
| 118 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.37307053 |
| 119 | positive regulation of macrophage differentiation (GO:0045651) | 2.37155916 |
| 120 | regulation of sequestering of triglyceride (GO:0010889) | 2.35587525 |
| 121 | positive regulation of lipid catabolic process (GO:0050996) | 2.35480556 |
| 122 | negative regulation of lipase activity (GO:0060192) | 2.31010357 |
| 123 | fatty acid beta-oxidation (GO:0006635) | 2.29980692 |
| 124 | creatine metabolic process (GO:0006600) | 2.29344902 |
| 125 | short-chain fatty acid metabolic process (GO:0046459) | 2.26448890 |
| 126 | regulation of cholesterol storage (GO:0010885) | 2.25123072 |
| 127 | positive regulation of p38MAPK cascade (GO:1900745) | 2.24029965 |
| 128 | protein localization to endosome (GO:0036010) | 2.23831229 |
| 129 | fatty acid oxidation (GO:0019395) | 2.22272860 |
| 130 | triglyceride homeostasis (GO:0070328) | 2.21721351 |
| 131 | acylglycerol homeostasis (GO:0055090) | 2.21721351 |
| 132 | lipid oxidation (GO:0034440) | 2.20671087 |
| 133 | response to lipoprotein particle (GO:0055094) | 2.20411751 |
| 134 | reverse cholesterol transport (GO:0043691) | 2.19583633 |
| 135 | positive regulation of fatty acid oxidation (GO:0046321) | 2.18670660 |
| 136 | negative regulation of fibrinolysis (GO:0051918) | 2.18277074 |
| 137 | negative regulation of lipid storage (GO:0010888) | 2.17858830 |
| 138 | regulation of protein activation cascade (GO:2000257) | 2.17564226 |
| 139 | regulation of fibrinolysis (GO:0051917) | 2.17161996 |
| 140 | high-density lipoprotein particle remodeling (GO:0034375) | 2.17082788 |
| 141 | transcytosis (GO:0045056) | 2.15365793 |
| 142 | fatty acid catabolic process (GO:0009062) | 2.15087770 |
| 143 | regulation of cholesterol esterification (GO:0010872) | 2.14498798 |
| 144 | bile acid metabolic process (GO:0008206) | 2.13345980 |
| 145 | indole-containing compound catabolic process (GO:0042436) | 2.12807911 |
| 146 | indolalkylamine catabolic process (GO:0046218) | 2.12807911 |
| 147 | tryptophan catabolic process (GO:0006569) | 2.12807911 |
| 148 | cholesterol efflux (GO:0033344) | 2.12315874 |
| 149 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.12092799 |
| 150 | fatty acid transmembrane transport (GO:1902001) | 2.11950334 |
| 151 | protein-lipid complex remodeling (GO:0034368) | 2.10372218 |
| 152 | macromolecular complex remodeling (GO:0034367) | 2.10372218 |
| 153 | plasma lipoprotein particle remodeling (GO:0034369) | 2.10372218 |
| 154 | regulation of complement activation (GO:0030449) | 2.09688251 |
| 155 | regulation of cholesterol homeostasis (GO:2000188) | 2.09396758 |
| 156 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.07997210 |
| 157 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.07796280 |
| 158 | triglyceride catabolic process (GO:0019433) | 2.07005150 |
| 159 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.06125708 |
| 160 | regulation of lipoprotein metabolic process (GO:0050746) | 2.04830959 |
| 161 | urea metabolic process (GO:0019627) | 2.04580201 |
| 162 | urea cycle (GO:0000050) | 2.04580201 |
| 163 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.04397566 |
| 164 | kynurenine metabolic process (GO:0070189) | 2.04169168 |
| 165 | very long-chain fatty acid metabolic process (GO:0000038) | 2.04049772 |
| 166 | acylglycerol catabolic process (GO:0046464) | 2.03820947 |
| 167 | neutral lipid catabolic process (GO:0046461) | 2.03820947 |
| 168 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.03776311 |
| 169 | tryptophan metabolic process (GO:0006568) | 2.03202845 |
| 170 | low-density lipoprotein particle remodeling (GO:0034374) | 2.02384861 |
| 171 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.01593224 |
| 172 | cellular response to ethanol (GO:0071361) | 2.01284917 |
| 173 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 1.99882755 |
| 174 | protein-lipid complex assembly (GO:0065005) | 1.99456321 |
| 175 | regulation of triglyceride metabolic process (GO:0090207) | 1.99064339 |
| 176 | regulation of cholesterol metabolic process (GO:0090181) | 1.98967172 |
| 177 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 1.98542652 |
| 178 | drug transmembrane transport (GO:0006855) | 1.98440566 |
| 179 | sulfur amino acid catabolic process (GO:0000098) | 1.97219913 |
| 180 | monocarboxylic acid catabolic process (GO:0072329) | 1.96998014 |
| 181 | positive regulation of cholesterol transport (GO:0032376) | 1.96498787 |
| 182 | positive regulation of sterol transport (GO:0032373) | 1.96498787 |
| 183 | plasma lipoprotein particle assembly (GO:0034377) | 1.95726086 |
| 184 | negative regulation of protein autophosphorylation (GO:0031953) | 1.93987553 |
| 185 | cellular glucuronidation (GO:0052695) | 1.93694598 |
| 186 | cholesterol homeostasis (GO:0042632) | 1.92500419 |
| 187 | sterol homeostasis (GO:0055092) | 1.92380646 |
| 188 | thioester biosynthetic process (GO:0035384) | 1.92367028 |
| 189 | acyl-CoA biosynthetic process (GO:0071616) | 1.92367028 |
| 190 | cysteine metabolic process (GO:0006534) | 1.91670038 |
| 191 | positive regulation of coagulation (GO:0050820) | 1.91136541 |
| 192 | regulation of cholesterol biosynthetic process (GO:0045540) | 1.90527756 |
| 193 | homocysteine metabolic process (GO:0050667) | 1.90060213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.60476639 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.17466928 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.98920140 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.79289179 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68792517 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 2.54709107 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.50151156 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.49990705 |
| 9 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.31817290 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 2.28505974 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.28038570 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.24195081 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07231789 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.02449674 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.92458077 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.92211115 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 1.91481252 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.88714272 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87142116 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80688035 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77236106 |
| 22 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75485846 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.74823116 |
| 24 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.73344902 |
| 25 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68689766 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.67089775 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.66379742 |
| 28 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.66229868 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.65931763 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64957182 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63627219 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61845798 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58041036 |
| 34 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.56589125 |
| 35 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.56589125 |
| 36 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56329030 |
| 37 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54811489 |
| 38 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.49068303 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48253833 |
| 40 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.47178714 |
| 41 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.44471657 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43965370 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42863969 |
| 44 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.41467410 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40002666 |
| 46 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39428080 |
| 47 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.38798940 |
| 48 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.38798940 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38133424 |
| 50 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37926976 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.35806099 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35130912 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34574689 |
| 54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.33770313 |
| 55 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29452416 |
| 56 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.29341409 |
| 57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.27798521 |
| 58 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.27259201 |
| 59 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.26789670 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24921410 |
| 61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.24134986 |
| 62 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22650971 |
| 63 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.21981261 |
| 64 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.21836842 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21764698 |
| 66 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.21519555 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21380203 |
| 68 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20962295 |
| 69 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19590117 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19450940 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18903283 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18541208 |
| 73 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.17471379 |
| 74 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.15519345 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14772028 |
| 76 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.11197588 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10494993 |
| 78 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10125851 |
| 79 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.09677959 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08845297 |
| 81 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.08750586 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.08286886 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08229060 |
| 84 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07943286 |
| 85 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.07462061 |
| 86 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.07349301 |
| 87 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06602119 |
| 88 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06524470 |
| 89 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05898118 |
| 90 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05837423 |
| 91 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05060307 |
| 92 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04833188 |
| 93 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04824741 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04472133 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03128568 |
| 96 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02832489 |
| 97 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02788068 |
| 98 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02473482 |
| 99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02229627 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02009383 |
| 101 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.01234881 |
| 102 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00707438 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00353447 |
| 104 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00289521 |
| 105 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.00010730 |
| 106 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98576215 |
| 107 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98454175 |
| 108 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98374086 |
| 109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97947406 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96098218 |
| 111 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95911198 |
| 112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95638856 |
| 113 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.95312802 |
| 114 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95169274 |
| 115 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93474988 |
| 116 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93419488 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93348576 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93139976 |
| 119 | MAF_26560356_Chip-Seq_TH2_Human | 0.93080122 |
| 120 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92893056 |
| 121 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.91853416 |
| 122 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.91399494 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90806898 |
| 124 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90729482 |
| 125 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.90284485 |
| 126 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88444347 |
| 127 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.88070811 |
| 128 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.87611230 |
| 129 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.87406494 |
| 130 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87375454 |
| 131 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87146279 |
| 132 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86588148 |
| 133 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85911538 |
| 134 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85595338 |
| 135 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.85223267 |
| 136 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85186264 |
| 137 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.84863930 |
| 138 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.84183557 |
| 139 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.84183557 |
| 140 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83776139 |
| 141 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82282586 |
| 142 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82275840 |
| 143 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.82205933 |
| 144 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81849409 |
| 145 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81259341 |
| 146 | * TAF15_26573619_Chip-Seq_HEK293_Human | 0.81226970 |
| 147 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81193857 |
| 148 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81087485 |
| 149 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.80872854 |
| 150 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79898422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.42025597 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.13624416 |
| 3 | MP0003300_gastrointestinal_ulcer | 2.74294962 |
| 4 | MP0005365_abnormal_bile_salt | 2.68559223 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 2.61141090 |
| 6 | * MP0003763_abnormal_thymus_physiology | 2.59070691 |
| 7 | MP0003724_increased_susceptibility_to | 2.44944116 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.26400238 |
| 9 | MP0003252_abnormal_bile_duct | 2.24884476 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.02628899 |
| 11 | MP0010329_abnormal_lipoprotein_level | 1.99613241 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 1.98140869 |
| 13 | MP0003690_abnormal_glial_cell | 1.93484948 |
| 14 | MP0004130_abnormal_muscle_cell | 1.86505415 |
| 15 | MP0009840_abnormal_foam_cell | 1.86269472 |
| 16 | * MP0001819_abnormal_immune_cell | 1.85785251 |
| 17 | MP0002166_altered_tumor_susceptibility | 1.83082731 |
| 18 | MP0003091_abnormal_cell_migration | 1.77821873 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.71750393 |
| 20 | MP0003195_calcinosis | 1.71539827 |
| 21 | MP0002254_reproductive_system_inflammat | 1.65510069 |
| 22 | * MP0002398_abnormal_bone_marrow | 1.62178551 |
| 23 | MP0002405_respiratory_system_inflammati | 1.59898785 |
| 24 | MP0003303_peritoneal_inflammation | 1.59439275 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.58322492 |
| 26 | MP0001666_abnormal_nutrient_absorption | 1.58215857 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.53231386 |
| 28 | MP0005387_immune_system_phenotype | 1.52703300 |
| 29 | MP0001790_abnormal_immune_system | 1.52703300 |
| 30 | * MP0000716_abnormal_immune_system | 1.49719990 |
| 31 | * MP0002118_abnormal_lipid_homeostasis | 1.49515604 |
| 32 | MP0008057_abnormal_DNA_replication | 1.47790526 |
| 33 | MP0003075_altered_response_to | 1.47582878 |
| 34 | MP0000920_abnormal_myelination | 1.47382520 |
| 35 | MP0000604_amyloidosis | 1.46875212 |
| 36 | MP0005451_abnormal_body_composition | 1.46807411 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.46791856 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.46532069 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.42075342 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.41115700 |
| 41 | MP0005670_abnormal_white_adipose | 1.39294401 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.37559580 |
| 43 | MP0001873_stomach_inflammation | 1.37404655 |
| 44 | MP0005671_abnormal_response_to | 1.36947892 |
| 45 | MP0005275_abnormal_skin_tensile | 1.33869597 |
| 46 | MP0005332_abnormal_amino_acid | 1.33434717 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.31767998 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.31664351 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.31664351 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.31628278 |
| 51 | MP0004947_skin_inflammation | 1.31533263 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 1.28185123 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.27027177 |
| 54 | MP0002009_preneoplasia | 1.26828781 |
| 55 | MP0002722_abnormal_immune_system | 1.26514423 |
| 56 | MP0009785_altered_susceptibility_to | 1.26133360 |
| 57 | MP0002419_abnormal_innate_immunity | 1.25978521 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.25507816 |
| 59 | * MP0000609_abnormal_liver_physiology | 1.25256631 |
| 60 | MP0003045_fibrosis | 1.24835723 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.23534143 |
| 62 | MP0005083_abnormal_biliary_tract | 1.22724023 |
| 63 | MP0002332_abnormal_exercise_endurance | 1.22168076 |
| 64 | MP0003329_amyloid_beta_deposits | 1.21660627 |
| 65 | MP0003436_decreased_susceptibility_to | 1.21243226 |
| 66 | MP0006082_CNS_inflammation | 1.20034753 |
| 67 | * MP0005000_abnormal_immune_tolerance | 1.19677309 |
| 68 | * MP0002429_abnormal_blood_cell | 1.19405757 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.19039330 |
| 70 | MP0001853_heart_inflammation | 1.18355622 |
| 71 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.17406090 |
| 72 | MP0000685_abnormal_immune_system | 1.17339375 |
| 73 | MP0002006_tumorigenesis | 1.16873792 |
| 74 | MP0000858_altered_metastatic_potential | 1.16456288 |
| 75 | MP0010368_abnormal_lymphatic_system | 1.15178964 |
| 76 | MP0000703_abnormal_thymus_morphology | 1.14637573 |
| 77 | MP0002837_dystrophic_cardiac_calcinosis | 1.12605350 |
| 78 | MP0009278_abnormal_bone_marrow | 1.12182196 |
| 79 | MP0002971_abnormal_brown_adipose | 1.11827623 |
| 80 | MP0008260_abnormal_autophagy | 1.11234459 |
| 81 | MP0001851_eye_inflammation | 1.10704567 |
| 82 | MP0002933_joint_inflammation | 1.10552195 |
| 83 | MP0001800_abnormal_humoral_immune | 1.09914724 |
| 84 | MP0002148_abnormal_hypersensitivity_rea | 1.08945857 |
| 85 | MP0003566_abnormal_cell_adhesion | 1.08838244 |
| 86 | MP0005025_abnormal_response_to | 1.08449370 |
| 87 | MP0001879_abnormal_lymphatic_vessel | 1.06614670 |
| 88 | MP0005023_abnormal_wound_healing | 1.06045603 |
| 89 | MP0004381_abnormal_hair_follicle | 1.05857030 |
| 90 | MP0010678_abnormal_skin_adnexa | 1.05726090 |
| 91 | MP0005464_abnormal_platelet_physiology | 1.05548636 |
| 92 | MP0009764_decreased_sensitivity_to | 1.04900048 |
| 93 | * MP0008469_abnormal_protein_level | 1.03728674 |
| 94 | * MP0002998_abnormal_bone_remodeling | 1.03234047 |
| 95 | MP0002060_abnormal_skin_morphology | 1.03161978 |
| 96 | MP0000343_altered_response_to | 1.01817986 |
| 97 | MP0001348_abnormal_lacrimal_gland | 1.01100836 |
| 98 | MP0005310_abnormal_salivary_gland | 1.00826361 |
| 99 | MP0003448_altered_tumor_morphology | 1.00584478 |
| 100 | MP0003172_abnormal_lysosome_physiology | 1.00009195 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.98647658 |
| 102 | MP0004510_myositis | 0.98095061 |
| 103 | * MP0002723_abnormal_immune_serum | 0.97818811 |
| 104 | MP0005535_abnormal_body_temperature | 0.97612373 |
| 105 | MP0005164_abnormal_response_to | 0.96265224 |
| 106 | MP0005334_abnormal_fat_pad | 0.94109458 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 0.93539913 |
| 108 | MP0002452_abnormal_antigen_presenting | 0.93326986 |
| 109 | MP0004883_abnormal_blood_vessel | 0.92613206 |
| 110 | * MP0001845_abnormal_inflammatory_respons | 0.92486893 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.92407091 |
| 112 | MP0006054_spinal_hemorrhage | 0.92353657 |
| 113 | * MP0005375_adipose_tissue_phenotype | 0.92106005 |
| 114 | MP0003279_aneurysm | 0.92094343 |
| 115 | MP0003828_pulmonary_edema | 0.91362450 |
| 116 | * MP0005167_abnormal_blood-brain_barrier | 0.90835208 |
| 117 | MP0005166_decreased_susceptibility_to | 0.90816928 |
| 118 | MP0009384_cardiac_valve_regurgitation | 0.89038805 |
| 119 | MP0009643_abnormal_urine_homeostasis | 0.88389217 |
| 120 | MP0003950_abnormal_plasma_membrane | 0.88328201 |
| 121 | MP0002877_abnormal_melanocyte_morpholog | 0.88129889 |
| 122 | * MP0010155_abnormal_intestine_physiology | 0.86941005 |
| 123 | * MP0000249_abnormal_blood_vessel | 0.86841322 |
| 124 | MP0004036_abnormal_muscle_relaxation | 0.84630816 |
| 125 | MP0003866_abnormal_defecation | 0.82491133 |
| 126 | MP0003705_abnormal_hypodermis_morpholog | 0.82019873 |
| 127 | * MP0009763_increased_sensitivity_to | 0.81919637 |
| 128 | MP0001661_extended_life_span | 0.80681255 |
| 129 | MP0001881_abnormal_mammary_gland | 0.80627886 |
| 130 | MP0003183_abnormal_peptide_metabolism | 0.79721195 |
| 131 | MP0003868_abnormal_feces_composition | 0.79518008 |
| 132 | MP0001501_abnormal_sleep_pattern | 0.78741154 |
| 133 | MP0001958_emphysema | 0.78055166 |
| 134 | MP0004019_abnormal_vitamin_homeostasis | 0.78035873 |
| 135 | * MP0002420_abnormal_adaptive_immunity | 0.77407452 |
| 136 | MP0005165_increased_susceptibility_to | 0.77217727 |
| 137 | * MP0003795_abnormal_bone_structure | 0.75645920 |
| 138 | MP0000371_diluted_coat_color | 0.73988645 |
| 139 | MP0000015_abnormal_ear_pigmentation | 0.73072189 |
| 140 | MP0008004_abnormal_stomach_pH | 0.70951745 |
| 141 | MP0005390_skeleton_phenotype | 0.70935865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Xanthomatosis (HP:0000991) | 3.94125046 |
| 2 | Complement deficiency (HP:0004431) | 3.64973454 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 3.63948664 |
| 4 | Deep venous thrombosis (HP:0002625) | 3.55689022 |
| 5 | Myocardial infarction (HP:0001658) | 3.43359788 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 3.28801963 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.25734089 |
| 8 | Recurrent viral infections (HP:0004429) | 3.06594046 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.03692891 |
| 10 | Neurofibrillary tangles (HP:0002185) | 2.96157909 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 2.95259809 |
| 12 | Amyloidosis (HP:0011034) | 2.93470097 |
| 13 | Spondylolisthesis (HP:0003302) | 2.89173846 |
| 14 | Autoimmune hemolytic anemia (HP:0001890) | 2.87341738 |
| 15 | Recurrent fungal infections (HP:0002841) | 2.84768474 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 2.84110757 |
| 17 | Axonal loss (HP:0003447) | 2.81487808 |
| 18 | Prolonged partial thromboplastin time (HP:0003645) | 2.80680642 |
| 19 | Hypoglycemic coma (HP:0001325) | 2.79347497 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 2.76588378 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.74497490 |
| 22 | Meningitis (HP:0001287) | 2.74092568 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 2.73109218 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.73109218 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 2.66266842 |
| 26 | Pulmonary embolism (HP:0002204) | 2.65141945 |
| 27 | Joint hemorrhage (HP:0005261) | 2.63706647 |
| 28 | Epidermoid cyst (HP:0200040) | 2.63191730 |
| 29 | Hematochezia (HP:0002573) | 2.61387828 |
| 30 | Cellulitis (HP:0100658) | 2.59793878 |
| 31 | Stomatitis (HP:0010280) | 2.57712893 |
| 32 | Abnormality of complement system (HP:0005339) | 2.57303525 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 2.56118005 |
| 34 | Abnormality of macrophages (HP:0004311) | 2.54880704 |
| 35 | Abnormality of T cells (HP:0002843) | 2.52615754 |
| 36 | Colitis (HP:0002583) | 2.50502590 |
| 37 | Agammaglobulinemia (HP:0004432) | 2.47562298 |
| 38 | Nemaline bodies (HP:0003798) | 2.46288196 |
| 39 | Ketosis (HP:0001946) | 2.43290011 |
| 40 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.42362302 |
| 41 | Spontaneous hematomas (HP:0007420) | 2.41236935 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.38696139 |
| 43 | Fat malabsorption (HP:0002630) | 2.38654892 |
| 44 | Recurrent bronchitis (HP:0002837) | 2.37988501 |
| 45 | Hypercholesterolemia (HP:0003124) | 2.34427090 |
| 46 | Aortic aneurysm (HP:0004942) | 2.34304584 |
| 47 | Mitral stenosis (HP:0001718) | 2.32093150 |
| 48 | Gingival bleeding (HP:0000225) | 2.32055501 |
| 49 | Muscle fiber inclusion bodies (HP:0100299) | 2.32020486 |
| 50 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.31757075 |
| 51 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.31588022 |
| 52 | Type 1 muscle fiber predominance (HP:0003803) | 2.31240754 |
| 53 | Ketoacidosis (HP:0001993) | 2.31093851 |
| 54 | Orchitis (HP:0100796) | 2.30331476 |
| 55 | Glomerulonephritis (HP:0000099) | 2.25324782 |
| 56 | Hypolipoproteinemia (HP:0010981) | 2.24228267 |
| 57 | Abnormality of T cell physiology (HP:0011840) | 2.21650787 |
| 58 | Granulocytopenia (HP:0001913) | 2.21217893 |
| 59 | Cerebral inclusion bodies (HP:0100314) | 2.20196140 |
| 60 | Eosinophilia (HP:0001880) | 2.20104931 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.19983769 |
| 62 | Gingivitis (HP:0000230) | 2.19030847 |
| 63 | Dilatation of the ascending aorta (HP:0005111) | 2.16073196 |
| 64 | Osteomyelitis (HP:0002754) | 2.15942101 |
| 65 | Polycythemia (HP:0001901) | 2.14759203 |
| 66 | IgA deficiency (HP:0002720) | 2.13909343 |
| 67 | Pancreatitis (HP:0001733) | 2.13876700 |
| 68 | Recurrent bacterial skin infections (HP:0005406) | 2.13855991 |
| 69 | Chest pain (HP:0100749) | 2.13784136 |
| 70 | Viral hepatitis (HP:0006562) | 2.13725130 |
| 71 | Emphysema (HP:0002097) | 2.11721370 |
| 72 | Conjugated hyperbilirubinemia (HP:0002908) | 2.11338012 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.10361740 |
| 74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10361740 |
| 75 | Hyperammonemia (HP:0001987) | 2.10259298 |
| 76 | Spinal cord lesions (HP:0100561) | 2.09008763 |
| 77 | Syringomyelia (HP:0003396) | 2.09008763 |
| 78 | Skin nodule (HP:0200036) | 2.08132198 |
| 79 | Protrusio acetabuli (HP:0003179) | 2.07558144 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.07429332 |
| 81 | Increased connective tissue (HP:0009025) | 2.06522645 |
| 82 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.05460860 |
| 83 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.03550543 |
| 84 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.03441528 |
| 85 | Abnormality of glycolipid metabolism (HP:0010969) | 2.03441528 |
| 86 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.03441528 |
| 87 | Vascular calcification (HP:0004934) | 2.02960881 |
| 88 | Hypoglycemic seizures (HP:0002173) | 2.02558769 |
| 89 | Retrobulbar optic neuritis (HP:0100654) | 2.00910654 |
| 90 | Optic neuritis (HP:0100653) | 2.00910654 |
| 91 | Myositis (HP:0100614) | 2.00629176 |
| 92 | Leukocytosis (HP:0001974) | 2.00543784 |
| 93 | Subacute progressive viral hepatitis (HP:0006572) | 2.00440723 |
| 94 | Nephritis (HP:0000123) | 1.99872190 |
| 95 | Eczematoid dermatitis (HP:0000976) | 1.99777353 |
| 96 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.99624344 |
| 97 | IgG deficiency (HP:0004315) | 1.99568600 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 1.98813966 |
| 99 | Esophageal varix (HP:0002040) | 1.97285874 |
| 100 | Restrictive lung disease (HP:0002091) | 1.94986180 |
| 101 | Papilloma (HP:0012740) | 1.94813774 |
| 102 | Verrucae (HP:0200043) | 1.94813774 |
| 103 | Cerebral hemorrhage (HP:0001342) | 1.94095268 |
| 104 | Abnormality of the peritoneum (HP:0002585) | 1.93556031 |
| 105 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.93244113 |
| 106 | Encephalitis (HP:0002383) | 1.93059325 |
| 107 | Panhypogammaglobulinemia (HP:0003139) | 1.92542554 |
| 108 | Keratoconjunctivitis sicca (HP:0001097) | 1.92190233 |
| 109 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.91971604 |
| 110 | Peritonitis (HP:0002586) | 1.91515114 |
| 111 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90899845 |
| 112 | Dysostosis multiplex (HP:0000943) | 1.90794537 |
| 113 | Urticaria (HP:0001025) | 1.89255858 |
| 114 | Slow saccadic eye movements (HP:0000514) | 1.88528625 |
| 115 | Hyporeflexia of lower limbs (HP:0002600) | 1.87578145 |
| 116 | Thrombophlebitis (HP:0004418) | 1.87464269 |
| 117 | Thick nail (HP:0001805) | 1.86942282 |
| 118 | Vascular tortuosity (HP:0004948) | 1.86698164 |
| 119 | Acanthosis nigricans (HP:0000956) | 1.86577294 |
| 120 | Arterial thrombosis (HP:0004420) | 1.86086519 |
| 121 | Exercise-induced myalgia (HP:0003738) | 1.85869596 |
| 122 | Recurrent abscess formation (HP:0002722) | 1.84304700 |
| 123 | Abnormality of the intrinsic pathway (HP:0010989) | 1.83788085 |
| 124 | Vasculitis (HP:0002633) | 1.83399171 |
| 125 | Hemorrhage of the eye (HP:0011885) | 1.83015936 |
| 126 | Broad metatarsal (HP:0001783) | 1.82932676 |
| 127 | Hypobetalipoproteinemia (HP:0003563) | 1.82690981 |
| 128 | Periodontitis (HP:0000704) | 1.82160918 |
| 129 | Abnormality of T cell number (HP:0011839) | 1.81367872 |
| 130 | Hypertriglyceridemia (HP:0002155) | 1.81338153 |
| 131 | Pulmonary infiltrates (HP:0002113) | 1.81044117 |
| 132 | T lymphocytopenia (HP:0005403) | 1.80509695 |
| 133 | Abnormality of purine metabolism (HP:0004352) | 1.80185071 |
| 134 | Glomerulopathy (HP:0100820) | 1.78471593 |
| 135 | Epistaxis (HP:0000421) | 1.78140762 |
| 136 | Chronic otitis media (HP:0000389) | 1.78040407 |
| 137 | Abnormality of eosinophils (HP:0001879) | 1.78022370 |
| 138 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77897874 |
| 139 | Hypergammaglobulinemia (HP:0010702) | 1.77146560 |
| 140 | Glucose intolerance (HP:0000833) | 1.76702479 |
| 141 | Lymphopenia (HP:0001888) | 1.76511629 |
| 142 | Abnormality of the pleura (HP:0002103) | 1.76477555 |
| 143 | Vertebral compression fractures (HP:0002953) | 1.76383244 |
| 144 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.76192904 |
| 145 | Abnormality of glycine metabolism (HP:0010895) | 1.76192904 |
| 146 | Increased variability in muscle fiber diameter (HP:0003557) | 1.75819817 |
| 147 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.75768680 |
| 148 | Steatorrhea (HP:0002570) | 1.75569587 |
| 149 | Recurrent skin infections (HP:0001581) | 1.74906306 |
| 150 | Gastrointestinal stroma tumor (HP:0100723) | 1.74830136 |
| 151 | Aortic dissection (HP:0002647) | 1.74204790 |
| 152 | Increased IgE level (HP:0003212) | 1.73446438 |
| 153 | Vacuolated lymphocytes (HP:0001922) | 1.71801255 |
| 154 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.69268148 |
| 155 | Keratoconjunctivitis (HP:0001096) | 1.68954767 |
| 156 | Symptomatic seizures (HP:0011145) | 1.67721742 |
| 157 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.67351565 |
| 158 | Mucopolysacchariduria (HP:0008155) | 1.67351565 |
| 159 | Protuberant abdomen (HP:0001538) | 1.65696737 |
| 160 | Autoimmune thrombocytopenia (HP:0001973) | 1.65175275 |
| 161 | Abnormal platelet volume (HP:0011876) | 1.65156391 |
| 162 | Increased mean platelet volume (HP:0011877) | 1.63065450 |
| 163 | Pigmentary retinal degeneration (HP:0001146) | 1.62095003 |
| 164 | Right ventricular cardiomyopathy (HP:0011663) | 1.61838194 |
| 165 | Chronic diarrhea (HP:0002028) | 1.61059628 |
| 166 | Arterial tortuosity (HP:0005116) | 1.60483521 |
| 167 | Hemoptysis (HP:0002105) | 1.59954774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.01143238 |
| 2 | TXK | 2.52547858 |
| 3 | BMPR2 | 2.23874831 |
| 4 | TGFBR2 | 2.21451919 |
| 5 | EPHB1 | 2.12213877 |
| 6 | SIK1 | 2.09398627 |
| 7 | FRK | 2.07729634 |
| 8 | JAK1 | 2.07310974 |
| 9 | FGFR2 | 2.03073028 |
| 10 | MAP3K14 | 2.02677107 |
| 11 | TYK2 | 1.97694597 |
| 12 | MAP3K13 | 1.91344429 |
| 13 | CAMK1D | 1.89714267 |
| 14 | INSRR | 1.87678610 |
| 15 | MAP2K3 | 1.75722325 |
| 16 | FGFR4 | 1.74805436 |
| 17 | ERN1 | 1.74286913 |
| 18 | TAOK3 | 1.68447106 |
| 19 | CAMK1G | 1.61975289 |
| 20 | IRAK3 | 1.58248555 |
| 21 | MAP4K1 | 1.49782361 |
| 22 | RIPK4 | 1.46875450 |
| 23 | IKBKE | 1.42904180 |
| 24 | JAK3 | 1.41386883 |
| 25 | TBK1 | 1.30738798 |
| 26 | SCYL2 | 1.29947069 |
| 27 | JAK2 | 1.29893738 |
| 28 | STK39 | 1.29453016 |
| 29 | FGFR3 | 1.28791292 |
| 30 | NEK9 | 1.28503506 |
| 31 | TIE1 | 1.26032412 |
| 32 | ITK | 1.23734455 |
| 33 | PIK3CA | 1.21610145 |
| 34 | OBSCN | 1.21112177 |
| 35 | EIF2AK3 | 1.19619744 |
| 36 | MST1R | 1.18326876 |
| 37 | MAP3K7 | 1.16431793 |
| 38 | MOS | 1.15678524 |
| 39 | CDK12 | 1.14394801 |
| 40 | TRIB3 | 1.14117721 |
| 41 | CSK | 1.11762906 |
| 42 | OXSR1 | 1.10184053 |
| 43 | BCKDK | 1.09657549 |
| 44 | PRKCQ | 1.09214500 |
| 45 | PIK3CG | 1.07516887 |
| 46 | MAP3K2 | 1.07511414 |
| 47 | TTN | 1.06046370 |
| 48 | TRPM7 | 1.05123614 |
| 49 | PTK6 | 1.03993743 |
| 50 | CSF1R | 1.02827114 |
| 51 | PRKCH | 1.02260212 |
| 52 | DDR2 | 0.99697011 |
| 53 | MAPK15 | 0.96206801 |
| 54 | PDPK1 | 0.95938822 |
| 55 | MET | 0.94899942 |
| 56 | RIPK1 | 0.93753900 |
| 57 | PDK1 | 0.93109011 |
| 58 | GRK6 | 0.92174228 |
| 59 | KIT | 0.91806506 |
| 60 | MAPKAPK5 | 0.91300107 |
| 61 | DMPK | 0.91094750 |
| 62 | IKBKB | 0.90900933 |
| 63 | TEC | 0.90650558 |
| 64 | LYN | 0.90094335 |
| 65 | PRKAA2 | 0.89619347 |
| 66 | WNK1 | 0.89058414 |
| 67 | PDGFRB | 0.88938557 |
| 68 | MELK | 0.87676364 |
| 69 | PKN1 | 0.87062599 |
| 70 | HIPK2 | 0.84654681 |
| 71 | BLK | 0.84627255 |
| 72 | MARK3 | 0.84365111 |
| 73 | MAPK7 | 0.82076870 |
| 74 | NUAK1 | 0.79779901 |
| 75 | STK10 | 0.79681858 |
| 76 | PRKD1 | 0.78180408 |
| 77 | MAPK12 | 0.77715380 |
| 78 | TNK2 | 0.77404707 |
| 79 | LCK | 0.75693872 |
| 80 | IRAK4 | 0.74703775 |
| 81 | GRK7 | 0.73954356 |
| 82 | KSR2 | 0.72965553 |
| 83 | CHUK | 0.72900086 |
| 84 | TAOK2 | 0.72538400 |
| 85 | FES | 0.72061960 |
| 86 | CLK1 | 0.71891200 |
| 87 | CAMKK2 | 0.71854679 |
| 88 | HCK | 0.68649260 |
| 89 | RET | 0.67986926 |
| 90 | CDC42BPA | 0.67542515 |
| 91 | PIM1 | 0.67411068 |
| 92 | SIK3 | 0.66092285 |
| 93 | SGK2 | 0.65856019 |
| 94 | MAP3K1 | 0.64991299 |
| 95 | EPHA3 | 0.64889237 |
| 96 | LRRK2 | 0.64797168 |
| 97 | FGR | 0.64634256 |
| 98 | PDGFRA | 0.63670759 |
| 99 | BTK | 0.63207087 |
| 100 | MST4 | 0.63031289 |
| 101 | ZAP70 | 0.63003623 |
| 102 | PTK2B | 0.62721919 |
| 103 | RAF1 | 0.61242297 |
| 104 | SYK | 0.59607453 |
| 105 | NLK | 0.59580010 |
| 106 | LMTK2 | 0.58914022 |
| 107 | NTRK1 | 0.58013086 |
| 108 | CASK | 0.55337212 |
| 109 | IGF1R | 0.54925837 |
| 110 | * MAPK11 | 0.54568444 |
| 111 | MAP3K3 | 0.54182528 |
| 112 | STK24 | 0.53641602 |
| 113 | SGK3 | 0.52739361 |
| 114 | IRAK1 | 0.52631630 |
| 115 | GSK3A | 0.52566991 |
| 116 | FLT3 | 0.52211312 |
| 117 | AKT3 | 0.50574591 |
| 118 | CDK6 | 0.48612460 |
| 119 | FYN | 0.47004715 |
| 120 | PRKCE | 0.46916183 |
| 121 | ABL1 | 0.46593868 |
| 122 | PKN2 | 0.46501718 |
| 123 | CDK4 | 0.46458117 |
| 124 | WNK4 | 0.46219223 |
| 125 | DAPK2 | 0.44843192 |
| 126 | INSR | 0.44840196 |
| 127 | MAPKAPK2 | 0.41887741 |
| 128 | BRD4 | 0.41268418 |
| 129 | STK38 | 0.37831923 |
| 130 | CCNB1 | 0.34368465 |
| 131 | STK3 | 0.33567913 |
| 132 | YES1 | 0.33367563 |
| 133 | ARAF | 0.33184321 |
| 134 | MAP3K5 | 0.31520208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.36837917 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.46701382 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.43958022 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.41974651 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.24540697 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.90278498 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.83742863 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.80812385 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.74634023 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.73552657 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 1.72311287 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71300087 |
| 13 | Influenza A_Homo sapiens_hsa05164 | 1.65692936 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64326821 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.60191903 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59510268 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58405896 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55999006 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.52884516 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49695289 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.47093566 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.44542100 |
| 23 | Hepatitis B_Homo sapiens_hsa05161 | 1.41195712 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39209845 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37077567 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33687685 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33424228 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33102823 |
| 29 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.32072626 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.31575965 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.31415870 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.27395049 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24854703 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.24045757 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.23420344 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23353500 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.22544779 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21453206 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.20849412 |
| 40 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.18828652 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11995313 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.11698539 |
| 43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.11378603 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.10923662 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08027215 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.05240796 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00677119 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00585040 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99498864 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99108426 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98705826 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.98370624 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97801743 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95539261 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94249343 |
| 56 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.94163391 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93480665 |
| 58 | Leishmaniasis_Homo sapiens_hsa05140 | 0.91405424 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91032918 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90952652 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 0.89958279 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.89950284 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 0.89809740 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86930057 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 0.86382072 |
| 66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85964354 |
| 67 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.85114282 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84192928 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83613321 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82416479 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.79482895 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.78846523 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.77811329 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76921372 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75813192 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.75778790 |
| 77 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.75548306 |
| 78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75133585 |
| 79 | Prostate cancer_Homo sapiens_hsa05215 | 0.74419773 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74391776 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73948638 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73414292 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73223119 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71349578 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.69021273 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68191274 |
| 87 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66808822 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.66569042 |
| 89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66242945 |
| 90 | Allograft rejection_Homo sapiens_hsa05330 | 0.66136786 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65649245 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.65250967 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65023809 |
| 94 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64803028 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64731034 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64645216 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.64416350 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63826594 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61686863 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.59797335 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59428597 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58496189 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58032218 |
| 104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56435063 |
| 105 | Amoebiasis_Homo sapiens_hsa05146 | 0.55820140 |
| 106 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55519222 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55399074 |
| 108 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55117088 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55060636 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.54765470 |
| 111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53383470 |
| 112 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53324521 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52959701 |
| 114 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52928242 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52422238 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52116468 |
| 117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51987838 |
| 118 | Salivary secretion_Homo sapiens_hsa04970 | 0.50820810 |
| 119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50245031 |
| 120 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50011727 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49714411 |
| 122 | Asthma_Homo sapiens_hsa05310 | 0.49362716 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48840187 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48333177 |
| 125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46919241 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | 0.46390867 |
| 127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45637610 |
| 128 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.45518982 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45034370 |
| 130 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44249155 |
| 131 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44205671 |
| 132 | Endocytosis_Homo sapiens_hsa04144 | 0.44110396 |
| 133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43856298 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43852786 |
| 135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43599022 |
| 136 | Long-term potentiation_Homo sapiens_hsa04720 | 0.43351273 |
| 137 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42866164 |
| 138 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.42658979 |
| 139 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42166240 |
| 140 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42094597 |
| 141 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42005806 |
| 142 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41698854 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41658388 |
| 144 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41459018 |
| 145 | Measles_Homo sapiens_hsa05162 | 0.41016756 |
| 146 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40711203 |
| 147 | Prion diseases_Homo sapiens_hsa05020 | 0.40158615 |
| 148 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40137550 |
| 149 | Hepatitis C_Homo sapiens_hsa05160 | 0.38884065 |
| 150 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37130973 |
| 151 | Focal adhesion_Homo sapiens_hsa04510 | 0.36743333 |
| 152 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.35947441 |
| 153 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35452927 |
| 154 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34240084 |
| 155 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34236513 |
| 156 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33904626 |
| 157 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32461112 |
| 158 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32394868 |
| 159 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30771637 |

